INTRODUCTION
============

Screening endoscopy in asymptomatic populations is widely performed worldwide, and it has been reported to help prevent gastric cancer \[[@b1-kjim-2015-393]\]. However, some examinees experience difficulties in tolerating gastroscopy. In some cases, all parts of stomach cannot be observed for a sufficient time due to the examinee's poor cooperation. Furthermore, poor cooperation may increase the risk of complications after endoscopy and lower the detection rate of gastric lesions.

To date, few studies have been conducted to identify the factors involved in poor cooperation during screening upper endoscopy. Only one previous study has been reported, which showed that age and anxiety significantly correlated with patient cooperation during endoscopy \[[@b2-kjim-2015-393]\]. However, there may be a variety of factors affecting poor cooperation. Some people cannot suppress involuntary gagging even after pharyngeal anesthesia because of a sensitive gag reflex \[[@b3-kjim-2015-393]\]. Others may fail to stifle a belch due to a large hiatal hernia \[[@b4-kjim-2015-393],[@b5-kjim-2015-393]\].

Procedural sedation during endoscopy can maximize patients' comfort and satisfaction \[[@b6-kjim-2015-393],[@b7-kjim-2015-393]\]. The anterograde amnesic effect of midazolam makes the examinees unable to recall painful memories of the procedure. However, it may reduce the examinee's cooperation during the procedure, because it is difficult to obey the operator's commands under sedation, and sometimes, paradoxical reactions to midazolam can develop \[[@b8-kjim-2015-393]\]. In addition, many other factors may impact on the examinee's level of cooperation, including age, gender, underlying diseases, medication history, obesity, alcohol drinking, smoking, emotional stress, and depression.

Therefore, we investigated the factors that affect examinees' cooperation during screening upper endoscopy. In addition, we examined the effect of the examinee's cooperation on the completeness of the endoscopic examination and on complications after the procedure.

METHODS
=======

Patients and questionnaires
---------------------------

We retrospectively reviewed the records of health examinations at Konkuk University Medical Center (Seoul, Korea), from September 2013 to April 2015. Among these, records of individuals over 18 years of age who underwent a gastroscopy were included in the study. To reduce the effect of variations between endoscopists, only gastroscopies carried out by a single experienced endoscopist (S.P.L.) were included. The study was approved by the Institutional Review Board (IRB) of Konkuk University School of Medicine, which confirmed that the study was in accordance with the ethical guidelines of the Helsinki Declaration (KUH1010664), and it was registered in the Clinical Research Information Service (CRIS) ID: KCT0001512.

All the examinees filled out a self-reporting questionnaire, which included the following items: underlying disease, medication history, smoking, alcohol intake, dyspepsia symptoms, and levels of emotional stress and depression. Subjects' age, gender, height, weight, and endoscopic and histologic findings were also investigated. Heavy drinking was defined as consuming 15 drinks or more per week for men and eight drinks or more per week for women.

Endoscopic procedure
--------------------

Gastroscopy was performed using a standard upper endoscope (GF-260, Olympus, Tokyo, Japan; or EPK-I, Pentax, Tokyo, Japan). Lidocaine spray was routinely used. All examinees provided written consent to undergo the endoscopic procedures. Midazolam for procedural sedation was selectively administered just before the start of the procedure in accordance with the examinee's preference. The usual starting dose for producing moderate sedation was 1 to 3 mg based on age, gender, and medical conditions. The dose was increased to achieve an adequate level of sedation \[[@b6-kjim-2015-393]\]. According to the American Society of Anesthesiologists guidelines, moderate sedation is defined as a state in which patients respond purposefully to verbal command and their cardiovascular function is maintained \[[@b9-kjim-2015-393]\]. If a severe paradoxical reaction to midazolam occurred, it was immediately treated with flumazenil. If symptoms of midazolam overdose or midazolam side effects were noted, we tried to stabilize the vital signs of the patient first, and we considered the use of flumazenil. Symptoms of overdose or side effects included hypoxia, hypoventilation, hypotension, apnea, and central nervous system (CNS) depression. Oxygen supplementation was provided via a nasal cannula if the oxygen saturation level remained \< 90%, despite verbal and physical stimuli. Hypoxia was recorded only when supplemental oxygen was needed. The incidence of acute complications (abdominal pain, nausea, and vomiting) and late-onset complications (persisting throat pain, bowel perforation, and gastrointestinal \[GI\] bleeding) were investigated through chart review.

Definitions and review of the endoscopic reports
------------------------------------------------

The examinee's cooperation and the completeness of endoscopic examination were evaluated by the operator's subjective judgment and recorded directly after the examination. Information on the level of cooperation was collected through a review of the endoscopic reports. "Poor cooperation" meant lack of cooperation of the examinees during the procedure regardless of one's will. The immediate causes of poor cooperation included severe belching, retching, coughing, and non-compliance of the examinees. "Belching" was defined as the forceful expulsion of gas from stomach through the mouth and "retching" was defined as an involuntary spasm of ineffectual vomiting. "Coughing" was defined as a sudden noisy expulsion of air from the bronchus or lungs, which is triggered by aspiration. "Non-compliance" referred to an action in contrast to bearing and managing impulses to enable the operator to perform the procedure. The study was considered incomplete when some parts of the stomach could not be sufficiently visualized during the procedure. The causes of incomplete study included poor cooperation and a large amount of food materials in the stomach.

Endoscopic and histologic records were reviewed to identify the presence of digestive diseases, such as peptic ulcer disease, reflux esophagitis, GI tract masses, nodular gastritis, chronic atrophic gastritis, and metaplastic gastritis. The endoscopic findings were described based on the criteria of the Sydney classification \[[@b10-kjim-2015-393]\]. A diagnosis of erosive esophagitis was made in cases with hyperemic streaks or mucosal breaks on the lower esophagus. Minimal change lesions of the esophagus were excluded from this diagnosis. Peptic ulcer disease was diagnosed as a deep mucosal defect with evidence of submucosal invasion, excluding ulcer scars. Chronic atrophic gastritis was diagnosed when the mucosal and submucosal vessels were visible without full air distension \[[@b11-kjim-2015-393]\]. Nodular gastritis was defined as chicken-skin like mucosal changes or unusual goose-flesh appearance, and metaplastic gastritis was defined as uneven, irregular whitish patches or plaques \[[@b12-kjim-2015-393]\]. Diagnoses of adenoma and carcinoma were made based on the results of tissue biopsy.

Depression and emotional stress
-------------------------------

Depression and emotional stress were assessed using the Korean version of the Beck's Depression Inventory (K-BDI) and the Brief Encounter Psychosocial Instrument-Korean version (BEPSI-K) \[[@b13-kjim-2015-393],[@b14-kjim-2015-393]\]. The BEPSI-K consists of five self-administered items. A total score of 0 to 1.8 indicates a low level of stress; 1.8 to 2.8, a moderate level of stress; and more than 2.8, a high level of stress. The cut off value of 2.4 as a significant stressful status was set based on previous studies \[[@b15-kjim-2015-393],[@b16-kjim-2015-393]\]. The K-BDI is a 21-item self-report questionnaire. A total score of 0 to 9 signifies no depression; 10 to 15, mild depression; 16 to 23, moderate depression; and 24 to 63, severe depression. We considered a total score of ≥ 10 as positive for depression.

Definitions of functional dyspepsia
-----------------------------------

Based on the Rome III definition, functional dyspepsia was diagnosed when the subjects had symptoms of dyspepsia without any evidence of reflux esophagitis, peptic ulcer disease, postoperative stomach, upper GI cancers, or any structural disease on upper GI endoscopy. Dyspepsia was defined as one or more of the following symptoms occurring at least once per week in the last 3 months: (1) bothersome postprandial fullness after ordinary-sized meals, (2) early satiety that prevents finishing a regular meal, and (3) epigastric pain or burning. Symptoms with an onset occurring more than 6 months prior to the survey were not asked about in our questionnaire.

Statistical analysis
--------------------

Continuous variables and categorical variables were presented as mean ± standard deviation (SD) and number (%), respectively. Subjects were divided into the poor cooperation group and the good cooperation group, according to their level of cooperation during endoscopy. The characteristics of the two groups were compared using the chi-square test, Student *t* test, and Mann-Whitney *U* test. Logistic regression analyses were performed to estimate the odds ratio (OR) and 95% confidence interval (CI) for factors that could result in poor cooperation during endoscopy. Statistical analyses were conducted using SPSS software version 19.0 (IBM Co., Armonk, NY, USA), and a *p* \< 0.05 was considered statistically significant in all tests.

RESULTS
=======

Baseline characteristics of the subjects
----------------------------------------

A total of 4,422 subjects (56.5% male) were included in the study. The overall mean age and body mass index (BMI) were 45.19 ± 9.87 years (range, 18 to 86) and 23.57 ± 3.27 kg/m^2^ (range, 14.6 to 39.7), respectively ([Table 1](#t1-kjim-2015-393){ref-type="table"}). The number of subjects who received sedation (midazolam) during endoscopy was 3,164 (71.6%). Cooperation during the endoscopic procedure was poor in 358 subjects (8.1%). The other characteristics of the study population are shown in [Table 1](#t1-kjim-2015-393){ref-type="table"}.

The poor cooperation and good cooperation groups
------------------------------------------------

In the poor cooperation group, the cause of poor cooperation was not recorded in 214 cases. Of the patients with causes recorded, the causes of poor cooperation were belching in 114 subjects (79.2%), retching in 94 (65.3%), non-compliance in 18 (12.5%), and coughing in two (1.4%) ([Fig. 1](#f1-kjim-2015-393){ref-type="fig"}). Often, poor cooperation was caused by multiple reasons (79 subjects, 54.9%).

Poor cooperation was more common among younger subjects and in women (*p* \< 0.001 and *p* = 0.003, respectively) ([Table 2](#t2-kjim-2015-393){ref-type="table"}). When broken down by age group, cooperation was poor in 9.6% of those in their 20s or younger (18 of 187), 10.5% of those in their 30s (123 of 1,174), 7.9% of those in their 40s (134 of 1,702), 6.2% of those in their 50s (60 of 968), 5.9% of those in their 60s (17 of 287), and 5.8% of those in their 70s or older (six of 104) ([Fig. 2](#f2-kjim-2015-393){ref-type="fig"}). Subjects in the poor cooperation group had a higher proportion of non-smokers and a lower proportion of past smokers (*p* = 0.049). Poor cooperation was also related to a high BMI, hiatal hernia, and procedural sedation (*p* = 0.001, *p* = 0.017, and *p* \< 0.001, respectively). Emotional stress, depression, functional dyspepsia, alcohol intake, and medication history were not related with poor cooperation.

Among the subjects who received procedural sedation, 10 (3.2%) in the poor cooperation group and one in the good cooperation group were administered the antidote (flumazenil). In the good cooperation group, the reason for using the antidote was hypoxia that could not be alleviated with nasal cannula oxygenation. Three subjects in the poor cooperation group and 12 subjects in the good cooperation group developed complications after the procedure, with no significant difference between the two groups (*p* = 0.116). The endoscopic examination of 44 subjects was an "incomplete study." The causes of incomplete study were poor cooperation in 36 cases and large amounts of food materials in the stomach in eight cases.

Predisposing factors for examinees' poor cooperation
----------------------------------------------------

Logistic regression analysis revealed that that young age (\< 40 years) and female sex were independent predisposing factors for an examinee's poor cooperation during upper endoscopy (OR, 1.423; 95% CI, 1.125 to 1.801; *p* = 0.003) (OR, 1.670; 95% CI, 1.216 to 2.294; *p* = 0.002) ([Table 3](#t3-kjim-2015-393){ref-type="table"}). In addition, high BMI (≥ 25), hiatal hernia, and procedural sedation were also independent predisposing factors for poor cooperation (OR, 1.501; 95% CI, 1.165 to 1.935; *p* = 0.002) (OR, 2.235; 95% CI, 1.300 to 3.844; *p* = 0.004) (OR, 2.918; 95% CI, 2.083 to 4.088; *p* \< 0.001). After logistic analysis, smoking history was not related with examinees' poor cooperation.

DISCUSSION
==========

Our study showed that 8.1% of examinees cooperated poorly with elective gastroscopy. This indicates that a considerable number of examinees have difficulty when undergoing gastroscopy. The main predisposing factor for poor cooperation was sedation using midazolam. The risk of poor cooperation in subjects who received sedation was three times higher than that in subjects who did not receive sedation. Sedation can assuage patients' fears about receiving endoscopy and maximize patient comfort during the procedure \[[@b6-kjim-2015-393],[@b7-kjim-2015-393],[@b9-kjim-2015-393]\]. However, a patient under sedation may not be able to obey the doctor's commands. For example, when patients cannot suppress a belch during endoscopy, doctor can instruct them to hold their breath for a while. Likewise, doctor can direct not to swallow saliva to prevent coughing. However, it is difficult for patients under sedation to carry out the instructions because of altered level of consciousness. In addition, paradoxical reactions to midazolam can sometimes develop. Therefore the outcome of previous endoscopic examinations should be examined to decide whether sedation is performed. If the examinee's cooperation was very poor in a previous endoscopy procedure under sedation, endoscopy without sedation should be considered.

Young age and female sex were predisposing factors for poor cooperation. Young people may not be able to suppress involuntary gagging due to a more sensitive gag reflex \[[@b3-kjim-2015-393]\]. Gender differences in pain sensitivity have become a focus of clinical interest in recent decades. Previous studies revealed that postoperative and procedural pain may be more severe among female than among male individuals \[[@b17-kjim-2015-393]\]. In addition, women have lower visceral pain thresholds \[[@b18-kjim-2015-393]\].

Hiatal hernia and obesity were also significantly associated with poor cooperation. People with a hiatal hernia may fail to stifle a belch during the endoscopic procedure, which can interrupt observation. Obesity can cause hiatal hernia \[[@b5-kjim-2015-393],[@b19-kjim-2015-393],[@b20-kjim-2015-393]\]. However, regardless of the existence of hiatal hernia, obesity can increase intra-abdominal pressure, and the increased pressure can obstruct air inflation during endoscopy \[[@b19-kjim-2015-393]\]. Thus it can prevent the stomach from expanding and interrupt observation. Although overall, the majority of females, young people, obese people, and people with hiatal hernias underwent endoscopy relatively well in our study, before performing the procedure in these patients, endoscopists should keep in mind that cooperation may be poor.

The causes of poor cooperation in this study were diverse, including belching, retching, non-compliance, and coughing. However, it was often caused by several factors, meaning that sometimes a cause cannot be determined. Belching and retching especially often occurred together. In practice, however, it is difficult to distinguish belching from retching in many cases. Non-compliance can be caused by anxiety related to fear or to paradoxical reactions to midazolam. If a paradoxical reaction was suspected during endoscopy, antidote was administered without delay. In our study, 10 examinees received flumazenil due to non-compliance, in all of whom the endoscopic examination was finished safely.

The manifestations of midazolam overdose or side effects include hypoxia, hypoventilation, hypotension, apnea, and CNS depression \[[@b6-kjim-2015-393]\]. In our study, there were few severe symptoms of overdose or side effect, and the most common symptom that occurred was hypoxia. Most cases of hypoxia resolved with conservative treatment, with only one case requiring the use of flumazenil because of hypoxia.

Our study showed that about 10% of endoscopic examinations in the poor cooperation group were incomplete. In addition, cases of adenoma and adenocarcinoma were not detected in the poor cooperation group. Although the sample size was small, these results revealed that the examinee's poor cooperation can interfere with adequate stomach observation.

This study has some limitations. First, the endoscopist's judgment of poor cooperation is bound to be subjective. We therefore investigated the records of procedures performed by only one endoscopist to minimize bias and inter-individual variance of endoscopists. Second, some procedural complications may have been overlooked. Mild oral bleeding or throat pain after the procedure might not be included in a patient's record, because the examinees can leave the hospital without complaint. Third, there were some missing values. The BMI of 23 subjects, K-BDI of 126 subjects, BEPSI-K of 495 subjects, smoking history of 439 subjects, drinking status of 196 subjects, and dyspepsia symptoms of 250 subjects were not measured or were not recorded. The cause of poor cooperation was also not recorded in 214 subjects. Lastly, although we measured the level of emotional stress and depression, which had no effect on the examinee's cooperation, the anxiety level of the examinees was not measured.

In conclusion, cooperation during elective gastroscopy was poor in a considerable number of examinees. Poor cooperation did not lead to more frequent complications but could sometimes cause incomplete study. Endoscopists must keep in mind that cooperation is more likely to be poor in young people, obese people, women, those with hiatal hernia, and those who received sedation during the examination.

KEY MESSAGE
===========

1\. Cooperation during gastroscopy is poor in a considerable number of examinees and poor cooperation sometimes causes incomplete study.

2\. Cooperation during gastroscopy is more likely to be poor in young people, obese people, women, those with hiatal hernia, and those who received sedation.
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![Venn diagram of the causes of poor cooperation. In 214 subjects, the causes of poor cooperation were not recorded. After their exclusion, the causes of poor cooperation were belching in 114 subjects (79.2%), retching in 94 (65.3%), non-compliance in 18 (12.5%), and coughing in two (1.4%). Poor cooperation was often caused by multiple reasons (79 subjects, 54.9%). Belching and retching frequently occurred together.](kjim-2015-393f1){#f1-kjim-2015-393}

![Percentages of subjects with poor cooperation by age group. Examinees' cooperation was poor in 9.6% of those in their 20s or younger (18 of 187), 10.5% of those in their 30s (123 of 1,174), 7.9% of those in their 40s (134 of 1,702), 6.2% of those in their 50s (60 of 968), 5.9% of those in their 60s (17 of 287), and 5.8% of those in their 70s or older (six of 104). Among the subjects under 40, the percentage of subjects with poor cooperation was above average.](kjim-2015-393f2){#f2-kjim-2015-393}

###### 

Baseline characteristics of the subjects (n = 4,422)

  Variable                            No. (%)        Mean ± SD       Median (range)
  ----------------------------------- -------------- --------------- --------------------
  Age, yr                                            45.19 ± 10.44   44 (18--86)
  Male sex                            2,498 (56.5)                   
  Body mass index, kg/m^2^                           23.57 ± 3.27    23.31 (14.6--39.7)
   ≥ 25                               1,339 (30.4)                   
   ≥ 18.5 and \< 25                   2,882 (65.5)                   
   \< 18.5                            178 (4.1)                      
  K-BDI level                                        2.22 ± 4.05     0 (0--46)
   No depression                      4,123 (96.0)                   
   Mild                               96 (2.2)                       
   Moderate                           61 (1.4)                       
   Severe                             16 (0.4)                       
  BEPSI-K level                                      1.61 ± 0.83     1.4 (0--5)
   Low level of stress                2,488 (63.4)                   
   Moderate level                     931 (23.7)                     
   High level                         508 (12.9)                     
  Smoking                                                            
   Non-smoker                         2,131 (53.5)                   
   Past smoker                        1,004 (25.2)                   
   Current smoker                     848 (21.3)                     
  Alcohol                                                            
   Non-drinker                        857 (20.3)                     
   Social drinker                     3,224 (76.3)                   
   Heavy drinker                      145 (3.4)                      
  Comorbidity                                                        
   Diabetes                           196 (4.4)                      
   Hypertension                       543 (12.3)                     
   Congestive heart disease           68 (1.5)                       
   Stroke                             5 (0.1)                        
  Medication                                                         
   Antiplatelet agent                 76 (1.7)                       
   Anticoagulant                      6 (0.1)                        
   NSAID                              226 (5.1)                      
   Antidepressant                     22 (0.5)                       
   Herb and health food               750 (17.0)                     
  Symptoms of dyspepsia               691 (16.6)                     
   Postprandial fullness              470 (11.3)                     
   Early satiety                      280 (6.7)                      
   Epigastric pain/burning            218 (5.2)                      
  Procedural sedation                 3,164 (71.6)                   
   Dose of midazolam, mg                             3.69 ± 0.67     4 (1--7)
  Poor cooperation during endoscopy   358 (8.1)                      

BMI, K-BDI, BEPSI-K, smoking, drinking, and dyspepsia symptoms were not properly measured in 23, 126, 495, 439, 196, and 250 subjects, respectively.

SD, standard deviation; K-BDI, Korean version of the Beck's Depression Inventory; BEPSI-K, The Brief Encounter Psychosocial Instrument-Korean version; NSAID, nonsteroidal anti-inflammatory drug.

###### 

Comparison between the poor cooperation and good cooperation group

  Variable                                                                  Poor cooperation group (n = 358)   Good cooperation group (n = 4,064)   *p* value
  ------------------------------------------------------------------------- ---------------------------------- ------------------------------------ ---------------------------------------------------------
  Age^[a](#tfn1-kjim-2015-393){ref-type="table-fn"}^, yr                    43.40 ± 9.87                       45.35 ± 10.48                        \< 0.001^[b](#tfn2-kjim-2015-393){ref-type="table-fn"}^
   \< 40                                                                    141 (39.4)                         1,220 (30.0)                         \< 0.001^[b](#tfn2-kjim-2015-393){ref-type="table-fn"}^
  Female sex                                                                183 (51.1)                         1,741 (42.8)                         0.003^[b](#tfn2-kjim-2015-393){ref-type="table-fn"}^
  Body mass index^[a](#tfn1-kjim-2015-393){ref-type="table-fn"}^, kg/m^2^   24.17 ± 3.37                       23.52 ± 3.25                         0.001^[b](#tfn2-kjim-2015-393){ref-type="table-fn"}^
   ≥ 25                                                                     130 (36.6)                         1,209 (29.9)                         0.010^[b](#tfn2-kjim-2015-393){ref-type="table-fn"}^
  Smoking                                                                                                                                           0.049^[b](#tfn2-kjim-2015-393){ref-type="table-fn"}^
   Non-smoker                                                               188 (57.7)                         1,943 (53.1)                         
   Past smoker                                                              64 (19.6)                          940 (25.7)                           
   Current smoker                                                           74 (22.7)                          774 (21.2)                           
  Alcohol                                                                                                                                           0.306
   Non-drinker                                                              78 (22.5)                          779 (20.1)                           
   Social drinker                                                           260 (75.1)                         2,964 (76.4)                         
   Heavy drinker                                                            8 (2.3)                            137 (3.5)                            
  Medication                                                                                                                                        
   Antidepressant                                                           0                                  22 (0.5)                             0.252
   NSAID                                                                    21 (5.9)                           205 (5.0)                            0.530
  K-BDI level ≥ 10                                                          19 (5.4)                           154 (3.9)                            0.200
  BEPSI-K level ≥ 2.4                                                       62 (19.4)                          710 (19.7)                           0.946
  First-time endoscopy                                                      27 (8.1)                           341 (9.0)                            0.618
  Procedural sedation                                                       316 (88.3)                         2,848 (70.1)                         \< 0.001^[b](#tfn2-kjim-2015-393){ref-type="table-fn"}^
   Midazolam side effect                                                                                                                            
    Hypotension                                                             0                                  1                                    
    Hypoxia                                                                 15                                 128                                  
   Use of flumazenil                                                        10                                 1                                    
  Digestive diseases                                                                                                                                
   Functional dyspepsia                                                     47 (13.9)                          595 (15.5)                           0.434
   Nodular gastritis                                                        3 (0.8)                            44 (1.1)                             1.000
   Chronic Atrophic gastritis                                               215 (60.1)                         2,350 (57.8)                         0.434
   Metaplastic gastritis                                                    23 (6.4)                           240 (5.9)                            0.726
   Reflux esophagitis                                                       22 (6.1)                           209 (5.1)                            0.456
   Peptic ulcer disease                                                     5 (1.4)                            88 (2.2)                             0.353
   Postoperative stomach                                                    1 (0.3)                            15 (0.4)                             1.000
   Gastric adenocarcinoma                                                   0                                  4                                    1.000
   Gastric adenoma                                                          0                                  6                                    1.000
   Hiatal hernia                                                            19 (5.3)                           118 (2.9)                            0.017^[b](#tfn2-kjim-2015-393){ref-type="table-fn"}^
  Complications                                                             3 (0.8)                            12 (0.3)                             0.116
   Persisting throat pain                                                   2                                  8                                    
   GI bleeding                                                              0                                  0                                    
   Bowel perforation                                                        0                                  0                                    
   Abdominal pain                                                           1                                  2                                    
   Nausea/Vomiting                                                          0                                  2                                    
  Incomplete study                                                          36 (10.1)                          8 (0.2)                              \< 0.001^[b](#tfn2-kjim-2015-393){ref-type="table-fn"}^
   Due to poor cooperation                                                  36                                 0                                    
   Due to food materials                                                    0                                  8                                    

Values are presented as mean ± SD or number (%).

NSAID, nonsteroidal anti-inflammatory drug; K-BDI, Korean version of the Beck's Depression Inventory; BEPSI-K, The Brief Encounter Psychosocial Instrument-Korean version.

Continuous variables were analyzed by the Mann-Whitney test. All other data were analyzed by the chi-square test.

The significant results.

###### 

Univariate and multivariate models of the predictors of examinee's poor cooperation during endoscopic procedure

  Variable               Univariate analysis    Multivariate analysis                                                                         
  ---------------------- ---------------------- ----------------------- --------------------------------------------------------------------- ---------------------------------------------------------
  Age \< 40              1.515 (1.213--1.892)   \< 0.001                1.423 (1.125--1.801)^[a](#tfn3-kjim-2015-393){ref-type="table-fn"}^   0.003^[a](#tfn3-kjim-2015-393){ref-type="table-fn"}^
  Female sex             1.395 (1.124--1.732)   0.003                   1.670 (1.216--2.294)^[a](#tfn3-kjim-2015-393){ref-type="table-fn"}^   0.002^[a](#tfn3-kjim-2015-393){ref-type="table-fn"}^
  Body mass index ≥ 25   1.355 (1.081--1.355)   0.008                   1.501 (1.165--1.935)^[a](#tfn3-kjim-2015-393){ref-type="table-fn"}^   0.002^[a](#tfn3-kjim-2015-393){ref-type="table-fn"}^
  Hiatal hernia          1.874 (1.140--3.081)   0.013                   2.235 (1.300--3.844)^[a](#tfn3-kjim-2015-393){ref-type="table-fn"}^   0.004^[a](#tfn3-kjim-2015-393){ref-type="table-fn"}^
  Procedural sedation    3.212 (2.312--4.463)   \< 0.001                2.918 (2.083--4.088)^[a](#tfn3-kjim-2015-393){ref-type="table-fn"}^   \< 0.001^[a](#tfn3-kjim-2015-393){ref-type="table-fn"}^
  Non-smoker             1.202 (0.956--1.511)   0.116                   \-                                                                    \-

OR, odds ratio; CI, confidence interval.

Univariate and multivariate logistic regression analyses were performed and footnotes are placed at the significant results.
